Whalegun
Home

Samuel Kintz, President and CEO: Enliven Therapeutics ELVN Sell · Filed 24/08/02

Trade details

Type
Insider sale
Amount
$62,561.2
Shares · price
2,270 sh · $27.56 a share
Held after
1,061,255 sh
Stock
Enliven Therapeutics ELVN
Person
Samuel KintzPresident and CEO
Trade date
24/07/31
Filed
24/08/02
Days to filing
2 days

Sold 0.2% of holdings

Share of holding sold
0.2%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/01~24/08/30

Samuel Kintz's recent trades

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $2M

    Filed 02/17

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $1.7M

    Filed 01/09

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $1.3M

    Filed 01/08

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $84.6K

    Filed 25/12/17

  • Samuel Kintz

    Sell10b5-1 planEnliven Therapeutics

    $272.8K

    Filed 25/11/19